Production (Stage)
Surgery Partners, Inc.
SGRY
$23.24
$0.441.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -193.40M | -168.10M | -60.60M | -33.80M | 600.00K |
| Total Depreciation and Amortization | 155.20M | 152.60M | 149.80M | 128.50M | 118.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 441.70M | 434.50M | 315.20M | 299.10M | 253.90M |
| Change in Net Operating Assets | -138.10M | -118.90M | -153.10M | -103.10M | -112.60M |
| Cash from Operations | 265.40M | 300.10M | 251.30M | 290.70M | 260.00M |
| Capital Expenditure | -92.10M | -90.40M | -87.90M | -86.60M | -85.50M |
| Sale of Property, Plant, and Equipment | 5.90M | 2.60M | 1.50M | 1.20M | 19.30M |
| Cash Acquisitions | -368.20M | -378.80M | -322.40M | -301.10M | -93.90M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.40M | -21.90M | -26.10M | -24.40M | -77.90M |
| Cash from Investing | -481.80M | -488.50M | -434.90M | -410.90M | -238.00M |
| Total Debt Issued | 1.75B | 1.73B | 2.17B | 2.10B | 1.00B |
| Total Debt Repaid | -1.28B | -1.28B | -1.81B | -1.75B | -911.40M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -211.90M | -188.40M | -192.80M | -189.80M | -174.10M |
| Cash from Financing | 260.50M | 262.00M | 169.40M | 156.30M | -82.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.10M | 73.60M | -14.20M | 36.10M | -60.30M |